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Association Between Patient Factors and Outcome of Synthetic Cartilage Implant 
Hemiarthroplasty versus First Metatarsophalangeal Joint Arthrodesis  
in Advanced Hallux Rigidus 
 
ABSTRACT (max 250 words) 
Background: We evaluated data from a clinical trial of first metatarsophalangeal joint 
(MTPJ1) implant hemiarthroplasty and arthrodesis to determine the association 
between patient factors and clinical outcomes.   
Methods: Patients ≥18 years with hallux rigidus grade 2, 3, or 4 were treated with 
synthetic cartilage implant MTPJ1 hemiarthroplasty or arthrodesis. Pain VAS, Foot and 
Ankle Ability Measure (FAAM) Sports and ADL scores, and SF-36 PF subscore were 
obtained preoperatively, and at 2, 6, 12, 24, 52 and 104 weeks postoperatively. Final 
outcome data, great toe active dorsiflexion motion, secondary procedures, radiographs 
and safety parameters were evaluated for 129 implant hemiarthroplasties and 47 
arthrodeses. The composite primary endpoint criteria for clinical success included VAS 
pain reduction ≥30%, maintenance/improvement in function, no radiographic 
complications, and no secondary surgical intervention at 24 months. Predictor variables 
included: hallux rigidus grade; gender; age; BMI; symptom duration; prior MTPJ1 
surgery; preoperative hallux valgus angle, ROM, and pain. Two-sided Fisher’s Exact test 
was used (p<0.05). 
Results: Patient demographics and baseline outcome measures were similar. Success 
rates between implant MTPJ1 hemiarthroplasty and arthrodesis were similar (p>0.05) 
when stratified by hallux rigidus grade, gender, age, BMI, symptom duration, prior 
MTPJ1 surgery status, and preoperative VAS pain, hallux valgus and ROM. 
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Conclusion: Synthetic cartilage implant hemiarthroplasty is appropriate for patients with 
grade 2, 3 or 4 hallux rigidus. Its results in those with associated mild hallux valgus (≤20°) 
or substantial preoperative stiffness are equivalent to MTPJ1 fusion, irrespective of 
gender, age, BMI, hallux rigidus grade, preoperative pain or symptom duration.  
Level of Evidence: II, randomized clinical trial 
Keywords: First metatarsophalangeal joint; Hallux rigidus; Hemiarthroplasty; Synthetic 
cartilage implant.   
 
 
INTRODUCTION 
Arthritis of the first metatarsophalangeal joint (MTPJ), or hallux rigidus, is a 
common problem affecting one in 40 people over 50 years of age11 and 45% of people 
aged 75 to 79 years21. Moderate to severe hallux rigidus is often treated with 
arthrodesis, historically considered the most reliable option.16 However, the loss of 
motion through the MTPJ following arthrodesis can interfere with activities that require 
great toe motion, such as jumping and running, or the wearing of high heels, and can 
lead to transfer metatarsalgia or adjacent joint arthritis. A desire to preserve motion at 
the first MTPJ has prompted the development of several great toe implants, many of 
which demonstrated high rates of failure due to loosening, malalignment, dislocation, 
subsidence, implant fragmentation and bone loss.23,24   
A polyvinyl alcohol (PVA) hydrogel implant has been developed for use in first 
MTPJ hemiarthroplasty. The PVA hydrogel has a cartilage-like viscoelasticity,18 a tensile 
strength of 17 MPa comparable to that of human articular cartilage,18 and 
biomechanical properties (i.e., compression-compressive modulus, shear-shear 
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modulus, compressive creep-creep and creep recovery, and kinetic friction) very similar 
to cartilage.2 Its high biocompatibility with cartilage, bone, synovium and muscle,18 
combined with its compressibility, low friction, and durable bearing surface make it a 
suitable synthetic cartilage implant.2,3 Since the implant has similar osmotic, physical 
and frictional properties to cartilage, replacement of the opposing articular surface is 
not required, permitting a hemiarthroplasty that maintains articulation through the 
joint. 
In a recent prospective, randomized, multicenter, clinical trial of 202 patients 
with moderate to severe hallux rigidus, hemiarthroplasty of the first MTPJ with a 
synthetic cartilage implant demonstrated equivalent pain relief, functional outcomes 
and safety to first MTPJ arthrodesis at two years follow-up, with no cases of implant 
fragmentation, wear or bone loss.4 First MTPJ active dorsiflexion motion improved by a 
mean of 6.2° (27.3%) in 152 synthetic cartilage implant hemiarthroplasty patients and 
was maintained at 24 months. In a subset of 27 implant hemiarthroplasty patients who 
reached five years follow-up, functional outcomes improved significantly and pain was 
reduced significantly compared to preoperative measures, and only one implant was 
removed and converted to fusion at two years postoperative, because of persistent 
pain.7 
There is a paucity of data regarding the association between patient factors and 
clinical outcomes following hallux rigidus surgery. Several studies have directly 
compared the short- to mid-term outcomes (i.e., 2 to 4 years) of first MTPJ 
hemiarthroplasty with various implants to MTPJ arthrodesis.9,10,13,17,19,20,22  However, 
these studies either did not evaluate the association between patient factors and 
outcomes,10,20,22 or the sample sizes were too small to permit such analyses.9,17,19   
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The purpose of this study was to evaluate the longitudinal data from the 
aforementioned randomized, clinical trial comparing synthetic cartilage implant first 
MTPJ hemiarthroplasty with arthrodesis,4 to determine the association between 
numerous patient factors and the success or failure of these procedures. Success rates 
were also compared between treatment groups within each category of the patient 
factors.   
 
PATIENTS AND METHODS 
Patients 18 years of age and older who had been diagnosed with Coughlin hallux 
rigidus grade 2, 3, or 4 based on combined radiological and clinical observations5 
including moderate to severe pain, and who were considered surgical candidates for 
arthrodesis, were treated with either hemiarthroplasty of the first MTPJ using a 
synthetic polyvinyl alcohol hydrogel implant (Cartiva® Synthetic Cartilage Implant, 
Cartiva, Inc., Alpharetta, GA, USA) or first MTPJ arthrodesis in a multicenter, non-
inferiority clinical trial, as previously reported.4 Patients were randomized 72 hours or 
less prior to surgery, in a 2:1 allotment of implant hemiarthroplasty to arthrodesis. The 
randomized clinical trial was approved by each site’s institutional review board, and all 
patients provided informed consent. The efficacy and safety data for the clinical trial 
have been previously reported.4  For the current study, patient demographic data and 
preoperative data collected prospectively for the original trial were assessed for the 
Safety population, comprising 152 hemiarthroplasties and 50 arthodeses (Figure 1). 
Osseous union was determined by independent radiographic review of foot radiographs, 
which were taken preoperatively and at 2, 6, 12, 24, 52 and 104 weeks postoperatively. 
A patient’s outcome was deemed successful if composite primary endpoint criteria for 
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clinical success were met at 24 months, namely: 1) VAS pain reduction ≥30%; 2) 
maintenance or improvement in function; 3) freedom from radiographic complications; 
and 4) no secondary surgical intervention. Final outcome data were assessed in the 
modified Intent to Treat (mITT) population (Figure 1).  
 The standardized operative technique used for the synthetic cartilage implant 
and postoperative protocol has been published previously.4,24 Briefly, the first MTPJ was 
accessed via a straight dorsal incision, or a standard mid-medial approach. The 
neurovascular structures and tendons were protected as appropriate and a capsular 
incision made to expose the first metatarsal (MT) head (Figure 2a). The articular 
cartilage wear was examined, and the medial, lateral and dorsal osteophytes were 
carefully removed from the metatarsal head; in some cases, the osteophyte on the 
dorsal side of the proximal phalanx was also removed (Figure 2b).  A central guide wire 
was placed in the MT head and extended into the shaft, and the MT head was drilled 
(Figures 2c, 2d). An appropriately sized 8 or 10 mm implant was seated in the MT head 
to allow approximately 1.5-2.0 mm of the implant to extend beyond the adjacent native 
cartilage (Figures 2e, 2f). With the implant at the correct depth, range of motion was 
checked against the implant, ensuring there was no restriction or limitation of the joint 
movement. Layered closure of the capsule and skin was performed. A soft dressing was 
applied, and postoperative shoes were used. Patients could bear weight immediately as 
tolerated. At 2 weeks, skin sutures were removed, range of motion (ROM) exercises 
were begun, and patients resumed wearing regular shoes, as tolerated. 
 First MTPJ arthrodesis was performed using standard techniques, as described in 
the literature.6 For this study, the first MTPJ was exposed as per the synthetic cartilage 
implant technique. The base of the proximal phalanx and the first MT head were aligned 
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and positioned in slight dorsiflexion and valgus with neutral rotation and held with K-
wires. A simulated weight bearing test was used to confirm grip of the big toe when 
plantigrade and sufficient lift off to enable comfortable walking. The construct was then 
stabilized with crossed screws or plate and screws. Layered closure of the capsule and 
skin were performed. The foot was placed in a sterile dressing and immobilized in a heel 
wedge shoe or boot for six to ten weeks, or until osseous union occurred, at which time 
weight bearing was begun at the discretion of the surgeon. 
Data Collection 
Outcome measures included a pain visual analogue scale (VAS), the Foot and 
Ankle Ability Measure (FAAM) Sports and Activities of Daily Living (ADL) subscales, and 
Short Form-36 Physical Functioning (SF-36 PF) subscore, which were prospectively 
recorded for all study patients preoperatively and at 2 (pain VAS and FAAM only), 6, 12, 
24, 52 and 104 weeks postoperatively. The Initiative on Methods, Measurement, and 
Pain Assessment in Clinical Trials (IMMPACT) consensus group defined a decrease in 
pain of ≥30% to be a clinically meaningful improvement for patients and recommended 
this value be reported in clinical trials.8 The FAAM has been validated in subjects with a 
leg, foot, or ankle musculoskeletal disorder;15 the minimal clinically important difference 
(MCID) is 9 points for the FAAM Sports score and 8 points for the FAAM ADL score.4 The 
SF-36 is a generic measure of general health status and has been validated in the end-
stage ankle arthritis population;14 the MCID for the SF-36 PF subscore is 3.3 points.1 
Great toe active dorsiflexion motion, secondary procedures, radiographs and safety 
parameters were also evaluated.  
Patient demographic and preoperative data assessed as predictor  
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variables included hallux rigidus grade,5 hallux valgus angle, preoperative ROM, gender, 
age, body mass index (BMI), preoperative symptom duration, preoperative pain level, 
and prior first MTPJ surgery (e.g. joint debridement or cheilectomy), all of which were 
captured prospectively at baseline.  
Statistical Analysis 
Categorical data are presented as numbers and percentages. Continuous data 
are presented as means and standard deviations with ranges. Two-sided Fisher’s Exact 
test was used to assess the association between patient demographic and preoperative 
variables and clinical success, within each treatment group. In secondary analyses, 
success rates were compared between groups within each level of the patient 
demographic and preoperative variables. A p-value <0.05 was considered statistically 
significant.  
 
RESULTS 
The original randomized clinical trial reported equivalent pain relief and 
functional outcomes in the synthetic implant first MTPJ hemiarthroplasty group and the 
first MTPJ arthrodesis group.4  Complete data at 24 months follow-up (mITT Completers; 
Figure 1) included 129 patients with synthetic cartilage implant hemiarthroplasty and 47 
patients who underwent an arthrodesis. Patient demographics and baseline outcome 
measures were similar for both groups (Table 1).  
There were no significant differences in success rates for either first MTPJ 
synthetic cartilage implant hemiarthroplasty or arthrodesis when stratified by hallux 
rigidus grade, degree of preoperative hallux valgus, extent of preoperative ROM, 
gender, age, BMI, duration of symptoms, prior MTPJ1 surgery status (including joint 
FAI-17-0187-R2 2017-Jun5  11 
 
debridement and/or cheilectomy), and preoperative VAS pain score (all p>0.05; Table 2). 
There were also no significant differences between treatment groups within any level of 
the patient or preoperative factors evaluated (Table 2). Males tended to have greater 
clinical success with implant hemiarthroplasty versus arthrodesis, but this difference 
was not statistically significant. Patients with less preoperative motion had marginally 
higher success rates with hemiarthroplasty versus fusion, but these differences were not 
statistically significant. 
 
DISCUSSION 
In a large, randomized, clinical trial, synthetic cartilage implant hemiarthroplasty 
of the first MTPJ demonstrated equivalent success rates compared to first MTPJ 
arthrodesis, regardless of hallux rigidus grade, gender, age, BMI, degree of preoperative 
hallux valgus, extent of preoperative ROM, preoperative duration of symptoms, prior 
first MTPJ surgery, and preoperative VAS pain score. Notably, patients with larger BMI, 
patients with minimal ROM (i.e., stiff joints), and patients with mild hallux valgus had 
equivalent success rates for both procedures, indicating that synthetic implant first 
MTPJ hemiarthroplasty could be considered as a reasonable operative option for 
moderate to severe hallux rigidus.  
Only one other study has compared the short-term outcomes (i.e., 2 to 3 years) 
of metatarsal head-resurfacing hemiarthroplasty to those of MTPJ arthrodesis. Erdil et 
al9 retrospectively reviewed patients with advanced hallux rigidus who underwent 
resurfacing hemiarthroplasty with the HemiCAP (n=14) or arthrodesis with 2 cannulated 
compression screws (n=12). They also had a third cohort of patients who underwent 
total joint arthroplasty with the ToeFit-Plus (n=12), They reported similar functional 
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outcomes following arthroplasty and hemiarthroplasty, and less function due to less 
range of motion in arthrodesis patients, who also had less pain, at 28 to 35 months 
follow-up. However, they did not evaluate the association between patient factors and 
clinical outcomes; there is a notable lack of such data available in the literature. 
To be included in the original clinical trial, patients had to be diagnosed with 
Coughlin grade 2, 3, or 4 hallux rigidus, which is based on a combination of radiological 
and clinical observations,5 and all patients had to be considered surgical candidates for 
arthrodesis. It is important to point out that Coughlin grade 2 includes moderate to 
severe pain and stiffness, which may be constant.5  
The literature generally holds that joint-sparing procedures should be reserved 
for mild to moderate osteoarthritis, and that fusion should be used in late-stage 
moderate to severe osteoarthritis.5,12,23 Our findings do not support this proposition, as 
we found no significant difference in outcome between the groups, irrespective of the 
hallux rigidus grade, preoperative presence of a stiff toe, a high BMI, or the presence of 
mild hallux valgus (≤20°).  
Synthetic implant first MTPJ hemiarthroplasty can be used to successfully treat 
patients with mild hallux valgus; however, patients with >20° hallux valgus were 
excluded from the clinical trial, and concomitant valgus correction procedures were also 
not permissible. Hence, we are unable to comment on the outcome of synthetic 
cartilage implant first MTPJ replacement in cases with >20° hallux valgus.   
We acknowledge the limitations of this study. The original clinical trial was 
powered for non-inferiority to demonstrate equivalence of the two procedures, 
whereas the current study retrospectively analyzed success rates for variations in 
patient factors within each treatment group and may not have been sufficiently 
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powered for some patient factors, thus a type II error cannot be excluded in the 
subgroup analysis. Some patient factors that may be associated with clinical outcomes 
may not have been recorded in the original trial. Exclusion criteria for the original trial 
also excluded some patient factors that would have been of interest to evaluate within 
the current study, such as the presence of hallux valgus >20° or an associated deformity 
correction. Another limitation is the loss of 15 patients who initially consented to 
randomization and treatment and subsequently withdrew from the original trial 
following randomization to arthrodesis; statistical analyses were therefore performed 
on the modified intent to treat population, so as to address the potential bias in favor of 
the implant. The current study did not assess surgeon factors such as type of approach, 
type of fixation used, or position of construct in the arthrodesis group, which could be 
confounding variables, and we intend to assess these in a subsequent study. Finally, this 
study evaluated association of patient factors based on two-year outcomes. As data for 
five years and longer follow-up become available, it is possible there may be some 
failures, which could potentially modify some of the associations observed here. 
Strengths of this study include the rigorous quality of the longitudinal data 
obtained as part of a large, multicenter, well controlled, randomized clinical trial, the 
large sample sizes (hemiarthroplasty n=129; arthrodesis n=47) and the low rate of 
patients lost to follow-up (2%). Most previous comparative studies of operative 
treatment for hallux rigidus have small numbers in each treatment arm.9,10,16,17,19,22 The 
data from this study are broadly generalizable, as they represent patients enrolled by 49 
surgeons from 12 centers across two countries. This study provides the first thorough 
evidence of the association between patient factors and clinical outcomes following 
hallux rigidus surgery. 
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In conclusion, based on our short-term data of two-year follow-up, synthetic 
cartilage implant hemiarthroplasty is an appropriate treatment for patients with hallux 
rigidus of Coughlin grade 2, 3 or 4. Our results demonstrate that it is a reasonable choice 
in hallux rigidus associated with mild hallux valgus (≤20°), and in patients with a high 
degree of preoperative stiffness, irrespective of gender, age, BMI, hallux rigidus grade, 
preoperative pain, or duration of symptoms, in contrast to what might have been 
expected.  
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Figure 1: Pivotal Trial Study Enrollment 
Subject accountability tree. The Safety Population consisted of 152 patients (22 roll-in 
and 130 randomized) treated with synthetic cartilage implant hemiarthroplasty and 50 
control patients treated with arthrodesis. The modified Intent to Treat (mITT) 
Population included 130 patients randomized and treated with synthetic cartilage 
implant hemiarthroplasty and 50 patients randomized and treated with arthrodesis, of 
whom 129 hemiarthroplasty and 47 arthrodesis patients had complete data available at 
24 months follow-up (mITT Completers) 
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Figure 2: Overview of operative technique for synthetic cartilage implant first 
metatarsophalangeal joint hemiarthroplasty: (a) Straight dorsal or medial incision and 
exposure of the entire joint to gain access to the first metatarsal head; (b) Resection of 
osteophytes from the metatarsal head; (c) Guide wire placement and advancement of 
the cannulated drill bit; (d) Drilling of metatarsal head to produce cavity for the implant; 
(e) Implant compressed within the introducer tube and positioned for insertion into the 
metatarsal head cavity; (f) Implant seated into metatarsal head with expected 1.5 to 2.0 
mm implant prominence. 
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Figure 2 
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Table 1: Baseline demographics and outcome measure scores of implant 
hemiarthroplasty and arthrodesis modified Intent to Treat (mITT) cohorts, shown as 
mean ± standard deviation, with the range in brackets 
Factor Implant  
Hemiarthroplasty 
(n=130) 
Arthrodesis 
(n=50) 
t-test 
p-valuea 
Wilcoxon 
p-valueb 
Age at surgery (years) 57.4 ± 8.8 
(30.5 – 79.2) 
54.9 ± 10.5 
(32.4 – 78.2) 
0.115 0.097 
Gender, n (%)   0.558 0.535 
     Male 26 (20%) 12 (24%)   
     Female 104 (80%) 38 (76%)   
BMI (kg/m2) 27.2 ± 4.4 
(19.1 – 37.1) 
26.3 ± 4.7 
(19.1 – 41.6) 
0.222 0.175 
Outcome Measures     
    VAS Pain 68.0 ± 13.9 
(27.8 – 100.0) 
69.3 ± 14.3 
(38.0 – 97.5) 
0.571 0.529 
    FAAM Sports 36.9 ± 20.9d 
(0.0 – 100.0) 
35.6 ± 20.5 
(0.0 – 87.5) 
0.694 0.502 
    FAAM ADL 59.4 ± 16.9c 
(7.1 – 100.0) 
56.0 ± 16.8 
(22.6 – 95.2) 
0.222 0.152 
    SF-36 PF 52.4 ± 22.8 
(0.0 – 100.0) 
49.8 ± 23.6 
(15.0 – 100.0) 
0.499 0.352 
Abbreviations:  BMI, body mass index; FAAM, Foot and Ankle Ability Measure; ADL, 
Activities of Daily Living; SF-36 PF, Short Form-36 Physical Function subscore 
aTwo-sample pooled t-test p-value (chi-square test for gender). 
bTwo-sample Wilcoxon rank-sum test p-value (Fisher’s exact test for gender). 
c n=129 for this score only. 
d n=127 for this score only  
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Table 2: Success rates of synthetic cartilage implant hemiarthroplasty of the first metatarsophalangeal joint (n=129) and first 
metatarsophalangeal joint arthrodesis (n=47), stratified by patient factors. 
 
Patient Variable Stratification Synthetic Implant 
Hemiarthroplasty 
Arthrodesis p-valueǂ 
  N^ n~ % Success p-value* N^ n~ % 
Success 
p-value*  
Coughlin5 Hallux 
Rigidus Grade 
2 36 26 72.2% 0.364 18 12 66.7% 0.331 0.756 
3 73 61 83.6%  20 17 85.0%  0.999 
4 20 16 80.0%  9 8 88.9%  0.999 
           
Preoperative Hallux 
Valgus Angle 
0 to <15° 101 81 80.2% 0.797 34 28 82.4% 0.429 0.999 
≥15° to ≤20° 28 22 78.6%  13 9 69.2%  0.698 
           
Preoperative Active 
Peak Dorsiflexion 
≥40° to ≤60° 10 7 70.0% 0.308 4 2 50.0% 0.357 0.580 
≥30° to <40° 22 17 77.3%  10 9 90.0%  0.637 
>10° to <30° 72 56 77.8%  26 21 80.1%  0.999 
≤10° 25 23 92.0%  7 5 71.4%  0.201 
           
Gender Female 104 81 77.9% 0.405 36 29 80.6% 0.679 0.817 
Male 25 22 88.0%  11 8 72.7%  0.343 
           
Age ≥65 years 22 20 90.9% 0.243 9 9 100% 0.172 0.999 
<65 years 107 83 77.6%  38 28 73.7%  0.659 
           
Body Mass Index 
(BMI) 
<30 kg/m2 94 76 80.9% 0.629 39 30 76.9% 0.667 0.640 
≥30 kg/m2 35 27 77.1%  8 7 87.5%  0.999 
           
Duration of 
Symptoms Prior to 
Surgery 
<24 months 15 10 66.7% 0.183 3 3 100% 1.000 0.522 
≥24 months 
114 93 81.6% 
 
44 34 77.3%  0.655 
           
Prior MTPJ1 Surgery Prior surgery1 12 8 66.7% 0.259 4 4 100% 0.564 0.516 
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Status No prior surgery 117 95 81.2%  43 33 76.7%  0.513 
           
Preoperative Pain 
VAS Score 
Mild (0 to <40 
mm)2 2 1 50.0% 
0.196 
2 1 50.0% 0.140 
0.999 
Moderate (≥40 to 
≤58 mm)  
27 24 88.9%  8 8 100.0% 
 
0.999 
Severe (>58 to 100 
mm) 
100 78 78.0%  37 28 75.7% 
 
0.819 
* p-values were determined using Fisher's Exact test, within group. 
ǂ p-values were determined using Fisher’s Exact test, between groups within strata. 
^ N = total number of patients in the treatment cohort with that variable. 
~ n = total number of patients in the treatment cohort with that variable who met the composite primary endpoint criteria 
for clinical success (i.e., VAS pain reduction ≥30%, maintenance or improvement in function, freedom from radiographic 
complications, and no secondary surgical intervention). 
1 Prior surgery other than arthroplasty or arthrodesis, for example, joint debridement or cheilectomy. 
2 VAS pain <40 mm was an exclusion criterion for the study; these patients were protocol violations. 
3Coughlin MJ, Shurnas PS. Hallux rigidus. Grading and long-term results of operative treatment. J Bone Joint Surg Am. 
2003;85-A(11):2072-2088. 
 
 
